Top compounds associated with response to CEP164


Feature Type Standardized
Nominal ANOVA
mRNA thapsigargin gCSI pan-cancer AAC 0.15 0.007
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.007
mRNA BIBW2992 CTRPv2 pan-cancer AAC -0.099 0.007
mRNA lapatinib CTRPv2 pan-cancer AAC -0.097 0.008
mRNA ibrutinib CTRPv2 pan-cancer AAC -0.11 0.008
mRNA thalidomide CTRPv2 pan-cancer AAC 0.15 0.008
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.093 0.009
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.096 0.01
mRNA VX-680 GDSC1000 pan-cancer AAC -0.14 0.01
mRNA Tamoxifen CTRPv2 pan-cancer AAC -0.097 0.01
Download CSV